SCHEMBL3786767

SCHEMBL3786767

Nc1ccc(-c2cc(Oc3ccccc3)ccc2N)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.62
ALDH1A1 P00352 6/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
MAPT P10636 3/20 0.58
MITF O75030 1/20 0.58
GAA P10253 1/20 0.58
GFER P55789 1/20 0.58
NLRP1 Q9C000 1/20 0.58
NOD2 Q9HC29 1/20 0.58
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
NLRP3 Q96P20 1/20 0.56
GSTP1 P09211 1/20 0.53
NCOA1 Q15788 1/20 0.53
NCOA3 Q9Y6Q9 1/20 0.53
MAOB P27338 2/20 0.52
LMNA P02545 1/20 0.49
GPR55 Q9Y2T6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21831936 0.95 NCOA1 (0.59) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1578431 0.91 MAOA (0.59) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3790623 0.91 GSTP1 (0.53) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL6574557 0.90 MAOA (0.57) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
Water SCHEMBL29113709 0.89 ALDH1A1 (0.50) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5014862 0.87 ALDH1A1 (0.52) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3790624 0.86 MAOA (0.62) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL25135231 0.85 MAOB (0.65) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3555602 0.84 NCOA1 (0.59) MAOAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3557154 0.84 NCOA1 (0.59) MAOAALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAOA 348/4885ALDH1A1 4339/4885MEN1 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.